Special Issue: GLP-1 agonists in Parkinson’s disease: New evidence, new questions?
MDS Podcast
00:00
Examining the Phase Three Trial of Exenatide in Parkinson's Disease
This chapter explores the design and outcomes of a phase three trial assessing Exenatide for Parkinson's treatment, detailing the evolution of prior studies and participant selection. Despite initial hopes for success, the trial results indicated no significant differences, leading to a discussion on possible reasons for these findings.
Transcript
Play full episode
